Shaligram D, Girimaji S C, Chaturvedi S K
Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.
Indian J Pediatr. 2007 Aug;74(8):727-30. doi: 10.1007/s12098-007-0127-6.
The study is aimed to assess psychological problems and quality of life (QOL) in children with thalassemia.
Thirty-nine children (8-16 yr) with transfusion dependent thalassemia attending day care services for blood transfusion were assessed for psychological problems using the Childhood Psychopathology Measurement Schedule and QOL was assessed using the EQ-5D.
Forty-four percent of the children had psychological problems and 74% had a poor QOL. Anxiety-related symptoms (67%), emotional problems, particularly depression (62%) and conduct problems (49%) were the main findings. The children were most likely to report impaired QOL due to severe difficulties in pain/discomfort (64%) dimension, followed by depression and mobility problems of equal severity (33%). The side effects of chelation were an independent predictor of psychological problems and impaired QOL. Also psychological problems were a significant predictor of impaired QOL.
The recognition and management of the psychological problems that accompany chronic physical illnesses including thalassemia would optimize treatment outcomes and QOL.
本研究旨在评估地中海贫血患儿的心理问题和生活质量(QOL)。
使用儿童精神病理学测量量表对39名年龄在8至16岁、依赖输血的地中海贫血患儿进行日间输血护理时的心理问题进行评估,并使用EQ-5D评估生活质量。
44%的患儿存在心理问题,74%的患儿生活质量较差。主要发现为与焦虑相关的症状(67%)、情绪问题,尤其是抑郁(62%)和行为问题(49%)。患儿最常报告因疼痛/不适维度的严重困难(64%)导致生活质量受损,其次是抑郁和同等严重程度的行动问题(33%)。螯合疗法的副作用是心理问题和生活质量受损的独立预测因素。此外,心理问题是生活质量受损的重要预测因素。
认识并处理包括地中海贫血在内的慢性躯体疾病所伴随的心理问题,将优化治疗效果和生活质量。